Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review

Central nervous system (CNS)‐relapsed mantle cell lymphoma (MCL) is a rare, aggressive non‐Hodgkin lymphoma without a standard treatment. Ibrutinib has shown promising results for inducing remission in other non‐Hodgkin lymphomas and may be considered as successful treatment for CNS‐relapsed MCL in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Case Rep
Autori principali: Rich, Jessica D., Clark, Stephen M., Fedoriw, Yuri, Jewells, Valerie, Wood, William, Dittus, Christopher
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Case Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6787781/
https://ncbi.nlm.nih.gov/pubmed/31624617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2257
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi